#semaglutide-ozempic-wegovy
#semaglutide-ozempic-wegovy

Health

New study of 77,000 patients reveals the hard truth about GLP1s

fromAlternative Medicine Magazine

Wellness

GLP-1s and the Thin Ideal

Alternative medicine

What is GLP-1?

What happens after Ozempic shocked researchers

Stopping GLP-1 medications like Ozempic does not typically lead to significant weight regain, as many patients switch treatments or restart therapy.

The Psychology of Ozempic

GLP-1 drugs reduce appetite and desire but may dampen all desires including healthy ones, potentially creating depression-like symptoms and reducing motivation for work, relationships, and life satisfaction.

1 day ago

The Dangerous Allure of Compounded GLP-1 Drugs

Compounded GLP-1 medications can be unsafe and unregulated, leading to serious health risks like acute liver failure.

Health

New study of 77,000 patients reveals the hard truth about GLP1s

Wellness

fromAlternative Medicine Magazine

GLP-1s and the Thin Ideal

GLP-1 medications in a culture equating thinness with worth risk reinforcing body surveillance, masking eating disorders, and creating harmful weight cycling patterns with psychological consequences.

Alternative medicine

What is GLP-1?

What happens after Ozempic shocked researchers

Stopping GLP-1 medications like Ozempic does not typically lead to significant weight regain, as many patients switch treatments or restart therapy.

The Psychology of Ozempic

more#glp-1-medications

20 hours ago

Gen Z wants their job to cover GLP-1 weight-loss drugs, survey suggests

A new ZipHealth survey of over 1,000 workers found that nearly half (47%) of Gen Z said GLP-1 coverage would affect their choices between two similar jobs.

Healthcare

The FDA approves a new obesity pill, giving patients another option

We've created a small molecule chemical which gets in your body very well. It can mimic the effects of the peptide and can be taken more conveniently any time of day without any food or water restrictions.

US news

Wegovy's new pricing could save you $1,200-but it's not for everyone

Novo Nordisk launched a subscription program for Wegovy to reduce cost uncertainty and improve access to obesity treatment.

fromwww.bbc.com

Weight-loss jabs will be offered on NHS for people at risk of further heart attacks

Wegovy will be provided for free on the NHS to over a million at-risk individuals in England to reduce heart attack and stroke risks.

NYC startup

Wegovy's new pricing could save you $1,200-but it's not for everyone

Novo Nordisk launched a subscription program for Wegovy to reduce cost uncertainty and improve access to obesity treatment.

fromwww.bbc.com

Weight-loss jabs will be offered on NHS for people at risk of further heart attacks

Wegovy will be provided for free on the NHS to over a million at-risk individuals in England to reduce heart attack and stroke risks.

more#wegovy

1 day ago

Is a new weight-loss drug making people fall out of love?

Retatrutide, an experimental weight-loss drug, may cause emotional flattening and affect relationships by dampening the brain's reward system.

What Weight-Loss Drugs Reveal About How We Judge Effort

Visible struggle in weight loss is often misinterpreted as greater effort, while underlying biological and psychological factors play a significant role.

fromABC7 New York

Medicine

FDA grants speedy approval to Eli Lilly's weight-loss pill for obesity

Medicine

US approves new oral weight-loss pill developed by Eli Lilly

Psychology

1 week ago

What Weight-Loss Drugs Reveal About How We Judge Effort

Visible struggle in weight loss is often misinterpreted as greater effort, while underlying biological and psychological factors play a significant role.

fromABC7 New York

FDA grants speedy approval to Eli Lilly's weight-loss pill for obesity

Eli Lilly's orforglipron, branded as Foundayo, is a new FDA-approved weight-loss pill expected to be available soon.

US approves new oral weight-loss pill developed by Eli Lilly

FDA approved orforglipron, a new oral weight-loss medication by Eli Lilly, offering an alternative to injectable GLP-1 treatments.

SF food

What does a 'GLP-1 Friendly' diet look like? We asked nutritionists

Medicine

A new weight loss pill is here and it could reshape the GLP-1 market

Marketing

Ro CEO on the next phase of the Ozempic boom

3 days ago

Medicine

A 59-year-old man lost 25 pounds on Foundayo, the new GLP-1 weight-loss pill

Medicine

A new weight-loss pill is here. Here's how Foundayo compares to Wegovy, Zepbound, and other GLP-1 rivals.

from24/7 Wall St.

Medicine

These 5 Biotechs Could Be the Next Big GLP-1 Acquisition Target

SF food

What does a 'GLP-1 Friendly' diet look like? We asked nutritionists

Food companies are branding products as 'GLP-1 Friendly' to cater to consumers using obesity and diabetes medications.

Medicine

A new weight loss pill is here and it could reshape the GLP-1 market

Marketing

Ro CEO on the next phase of the Ozempic boom

3 days ago

A 59-year-old man lost 25 pounds on Foundayo, the new GLP-1 weight-loss pill

Eli Lilly's Foundayo, the first once-daily GLP-1 pill for weight loss, has been approved by the FDA.

A new weight-loss pill is here. Here's how Foundayo compares to Wegovy, Zepbound, and other GLP-1 rivals.

Eli Lilly's Foundayo, a new weight loss pill, offers flexible dosing and outperforms competitors in weight loss and health metrics.

from24/7 Wall St.

These 5 Biotechs Could Be the Next Big GLP-1 Acquisition Target

The GLP-1 revolution is driving biopharma M&A strategies, with companies like Viking Therapeutics and Structure Therapeutics as prime acquisition targets.

Exercise

Strength persists after a mid-life course of obesity drugs

fromBusiness Insider

Healthcare

Eli Lilly is set to release a once-daily pill to rival Ozempic this year. People are losing 15 to 20 pounds on it, but there's a catch.

fromFuturism

Medicine

Scientists Just Found Something Rather Grim That Happens When You Stop Taking GLP-1s

Media industry

How weight-loss jabs are changing the way we spend money

fromHarvard Gazette

Health

Pricey blockbuster GLP-1s are costing users - and most of the rest of us, too - Harvard Gazette

Public health

Are obesity drugs causing a severe complication? What the science says

Exercise

Strength persists after a mid-life course of obesity drugs

fromBusiness Insider

Healthcare

Eli Lilly is set to release a once-daily pill to rival Ozempic this year. People are losing 15 to 20 pounds on it, but there's a catch.

fromFuturism

Scientists Just Found Something Rather Grim That Happens When You Stop Taking GLP-1s

Stopping GLP-1 drugs can quickly reverse health benefits, increasing cardiovascular risks and leading to weight regain and other health issues.

Media industry

How weight-loss jabs are changing the way we spend money

fromHarvard Gazette

Health

Pricey blockbuster GLP-1s are costing users - and most of the rest of us, too - Harvard Gazette

Public health

Are obesity drugs causing a severe complication? What the science says

more#glp-1-drugs

#fda-approval

The weight-loss drug rivalry heats up as another GLP-1 pill gains FDA approval

Eli Lilly's orforglipron received FDA approval as a weight loss treatment, showing significant weight loss in clinical trials.

Medicine

FDA approves higher-dose version of Wegovy shots

The weight-loss drug rivalry heats up as another GLP-1 pill gains FDA approval

Eli Lilly's orforglipron received FDA approval as a weight loss treatment, showing significant weight loss in clinical trials.

Medicine

FDA approves higher-dose version of Wegovy shots

FDA Approves Eli Lilly's GLP-1 Pill

The FDA approved Foundayo, a new daily obesity pill by Eli Lilly, expanding options for weight loss treatments alongside injectable GLP-1 medications.

Medicine

GLP-1 drugs don't work for everyone. But personalized obesity care in the future might

fromWIRED

FDA Approves Eli Lilly's GLP-1 Pill

The FDA approved Foundayo, a new daily obesity pill by Eli Lilly, expanding options for weight loss treatments alongside injectable GLP-1 medications.

Medicine

GLP-1 drugs don't work for everyone. But personalized obesity care in the future might

more#obesity

NHS England to offer weight-loss drugs to 1.2m people to reduce risk of heart attacks and strokes

NHS England will provide weight-loss drugs to over 1 million people to reduce heart attack and stroke risks.

Experimental GLP-3 weight loss drug retatrutide shows promising results in clinical trial

Retatrutide, a triple-receptor GLP-3 agonist drug, achieved up to 36.6 pounds of average weight loss and improved blood sugar control in phase 3 clinical trials for type 2 diabetes.

#glp-1-receptor-agonists

GLP-1 diabetes drugs could stop anxiety and depression worsening, study finds

GLP-1 receptor agonists, particularly semaglutide and liraglutide, reduce the risk of worsening anxiety and depression in people with diabetes.

Can weight-loss pills replace injectables? What the science says

Oral anti-obesity pills based on GLP-1 receptor agonists are entering the market, offering needle-free alternatives to injectable weight-loss drugs, though they produce less weight loss than injections.

Wegovy users have five times greater risk of sudden sight loss than Ozempic users, study finds

Wegovy users have nearly five times higher risk of sudden vision loss compared to Ozempic users, with risk appearing dose-dependent and higher in men.

Medicine

Weight loss drugs may stop people getting addicted to drugs and alcohol, study finds

Medicine

Head-to-head trial pitting Eli Lilly's oral GLP-1 against oral semaglutide underscores efficacy of weight-loss pills

Medicine

The next wave of GLP-1 drugs are comingand they're stronger than Wegovy and Zepbound

GLP-1 diabetes drugs could stop anxiety and depression worsening, study finds

GLP-1 receptor agonists, particularly semaglutide and liraglutide, reduce the risk of worsening anxiety and depression in people with diabetes.

Can weight-loss pills replace injectables? What the science says

Wegovy users have five times greater risk of sudden sight loss than Ozempic users, study finds

Wegovy users have nearly five times higher risk of sudden vision loss compared to Ozempic users, with risk appearing dose-dependent and higher in men.

Medicine

Weight loss drugs may stop people getting addicted to drugs and alcohol, study finds

Medicine

Head-to-head trial pitting Eli Lilly's oral GLP-1 against oral semaglutide underscores efficacy of weight-loss pills

more#glp-1-receptor-agonists

Medicine

The next wave of GLP-1 drugs are comingand they're stronger than Wegovy and Zepbound

Drugs like Ozempic are improving kidney treatment and changing lives

GLP-1 receptor agonists, finerenone, and SGLT2 inhibitors represent breakthrough treatments for chronic kidney disease, with combined therapy potentially adding decades to patients' lives.

Healthcare

Wegovy and Ozempic maker forecasts sharp drop in revenue for 2026

Novo Nordisk forecasts 5–13% revenue decline this year due to US price cuts, rising competition, and semaglutide patent expiries despite Wegovy pill uptake.

#ozempic

fromIrish Independent

Health

Real Health: From Stigma to Science: Aimee Donnellan on Ozempic

fromIndependent

Public health

Revealed: The massive HSE spend on weight-loss jabs like Ozempic - and which area is availing of the drugs most

fromIrish Independent

Health

Real Health: From Stigma to Science: Aimee Donnellan on Ozempic

fromIndependent

Public health

Revealed: The massive HSE spend on weight-loss jabs like Ozempic - and which area is availing of the drugs most

more#ozempic

fromBusiness Insider

People are using Ozempic to drink less. We already have FDA-approved drugs for that.

To some extent, Americans are talking about alcohol more than ever. We're having open conversations about the negative health impacts of drinking. People are consuming less booze overall and examining strategies to moderate, even as each drink packs more punch. There is one aspect of alcohol we're still not talking about: addiction, and, more precisely, the medical treatments available to combat it. What's even odder - your doctor may not know much about them, either.

Public health

#weight-loss-drugs

Public health

Off the Scales by Aimee Donnellan review inside the Ozempic revolution

fromBBC

Public health

Inside Health - What are the side effects of weight loss drugs? - BBC Sounds

Medicine

Experts suggest how to maintain weight loss after stopping Mounjaro and Ozempic jabs

Public health

Off the Scales by Aimee Donnellan review inside the Ozempic revolution

fromBBC

Public health

Inside Health - What are the side effects of weight loss drugs? - BBC Sounds

Medicine

Experts suggest how to maintain weight loss after stopping Mounjaro and Ozempic jabs

more#weight-loss-drugs

fromFortune

Health startup Noom is now adding weight loss injectables to its offerings, says 'outcomes are so much better' | Fortune

Noom launches Noom Med, combining GLP-1 obesity drugs like Wegovy with behavioral coaching for $120 monthly, joining competitors capitalizing on highly effective weight-loss medications.

fromIndependent

Weight-loss jab Wegovy has 'highest risk of rare eye stroke', study finds

Wegovy carries nearly five times higher risk of eye stroke and sudden sight loss compared to Ozempic, with men facing three times greater risk than women.

Weight-loss jab could be made for $3 a month, study finds

New research, published as a pre-print, suggests that semaglutide could be mass produced for $3 (about 2.35) for a monthly dose in its injectable form. Newer formulations, taken as a pill rather than an injection, could be made for about $16 a month.

Medicine

#glp-1-agonists

Medicine

Study raises red flags over long-term effectiveness of popular weight loss drugs like Ozempic

Medicine

The overlooked nutrition risk of Ozempic and Wegovy

Medicine

GLP-1 Anti-Obesity Rx and Alcohol and Substance Use Disorders

Medicine

Study raises red flags over long-term effectiveness of popular weight loss drugs like Ozempic

Medicine

The overlooked nutrition risk of Ozempic and Wegovy